Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

DCPH Deciphera Pharmaceuticals Inc

25,36

0,09 (0,36%)

02 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Deciphera Pharmaceuticals (NASDAQ:DCPH)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Deciphera Pharmaceuticals Charts.

Deciphera Pharmaceuticals (NASDAQ:DCPH)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Deciphera Pharmaceuticals Charts.

News Deciphera Pharmaceuticals Inc

Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion
Montag 29 April 2024 (3 Tage vor) • Business Wire

Deciphera Pharmaceuticals to Present at the Stifel 2024 Virtual Targeted Oncology Forum
Dienstag 9 April 2024 (3 Wochen vor) • Business Wire

Deciphera Pharmaceuticals to Participate in Upcoming Investor Conferences
Dienstag 27 Februar 2024 (2 Monate vor) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 20 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 20 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 20 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 9 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Freitag 9 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Mittwoch 7 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mittwoch 7 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 6 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Deciphera Pharmaceuticals Inc News-Artikel

JP Morgan Chase

BNP Paribas (QX)

Deutsche Telekom (QX)

Invesco QQQ Trust Series 1

Deutsche Lufthansa

Gold vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen